12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca deal

AstraZeneca sold its Aptium Oncology subsidiary to the five U.S. hospital-based outpatient cancer centers to which...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >